Synova Capital Current and past* investments References Navigation menuwww.synova-capital.com"Our Focus"
Private equity firms of the United KingdomBritish companies established in 2007
private equitygrowth companies
Type | Limited liability partnership |
---|---|
Industry | Private equity, venture capital |
Founded | 2007 |
Founders | David Menton Philip Shapiro |
Headquarters | London , United Kingdom |
Area served | United Kingdom |
Products | Venture capital, private equity funds, equity investment, management buy-in, management buyout |
AUM | £400 million |
Website | www.synova-capital.com |
Synova Capital is a private equity firm specialising in investments in UK and Irish growth companies.The firm manages over £400m of capital on behalf of institutional investors and family offices and invests across four sectors: Technology, Healthcare and Education, Business Services and Financial Services.[1] Synova is focused on working with management teams to accelerate growth and drive exceptional returns.
Synova was founded in 2007 by its managing partners, David Menton and Philip Shapiro. Synova's other partners include Tim Ashlin, Alex Bowden and Daniel Parker.
Synova was named 'Private Equity House of the Year' at the 'British Private Equity Awards' in 2016 and 2014.
2018 was a strong year for exits for Synova with the sale of software company Mandata to LDC generating a 8x return and the sale of medical imaging business 4ways to ECI for a 6x return and 75% IRR. This followed the sale of Kinapse to Hg Capital on 1 February 2016, generating a 16x return and a 126% IRR. Other notable exits include dbg for 6x cost and TLG for 3x cost.
2019 has continued in the same vain for Synova with further exits from Fund II including the sale of Stackhouse Poland to AJ Gallagher for a 5.6x return, the sale of Meritsoft to Cognizant for a 4.0x return and the sale of Defaqto to SimplyBiz plc for a 3.9x return.
Synova's 2007 Fund I was fully realised in 2018 generating a 4x return for investors. Synova's £110m 2013 Fund II has now returned three times its total invested capital following exits in 2018 and 2019 with only half the fund realised. Synova is currently investing its £250 million third fund.
Current and past* investments
Company | Year of investment | Return | Sector |
---|---|---|---|
TLG Brands* | 2008 - Exited 2016 | 3.0x | Consumer |
Clearwater Care* | 2009 - Exited 2017 | 2.0x | Healthcare |
dbg* | 2010 - Exited 2013 | 5.8x | Healthcare |
Kinapse* | 2012 - Exited 2016 | 16.1x | Healthcare |
Mandata* | 2013 - Exited 2018 | 8.0x | Technology |
MK Test | 2014 | Technology | |
Stackhouse Poland* | 2014 - Exited 2019 | 5.6x | Financial Services |
Defaqto* | 2015 - Exited 2019 | 3.9x | Technology |
4Ways Healthcare* | 2015 - Exited 2018 | 6.0x | Healthcare |
Merit Software* | 2015 - Exited 2019 | 4.0x | Technology |
Vistair | 2015 | Technology | |
Clyde Munro Dental | 2015 | Healthcare | |
Fleetway | 2015 | Technology | |
Fairstone | 2016 | Financial Services | |
Oakland | 2016 | Healthcare | |
Syslink | 2017 | Technology | |
AllClear | 2018 | Financial Services | |
Mintec | 2018 | Technology | |
Chatsworth Schools | 2019 | Education |
References
^ "Our Focus", Synova Capital. Retrieved on 6 July 2013.